Sep-Oct 2003
Relative Ortho-Directing Power of Fluorine, Chlorine and Methoxy Group
859
(deuteriochloroform, 300 MHz): δ = 8.01 d, 1H, J
= 3.8 Hz,
CH); 3.93 (s, 3H, OCH ); 3.51 (br, 1H, OH) 1.66 (m, 2H, CH );
3 2
H5-F
19
H ); 4.99 (m, 1H, CH); 3.89 (s, 3H, OCH ); 3.63 (br, 1H, OH) ;
1.33-1.17 (m, 6H, 3CH ); 0.77 (m, 3H, CH ); F NMR (deuteri-
5
3
2
3
13
1.42 (d, 3H, J = 6.4 Hz, CH ). C NMR (deuteriochloroform,
ochloroform, 300 MHz): δ = -88.21.
3
300 MHz): δ = 158.9 (C ); 155.0 (d, J
= 255.8 Hz, C );
Anal. Calcd. for C H FN O (228.27): C, 57.88; H, 7.51; N,
6
C2-F
2
11 17 2 2
135.9 (d, J
= 28.3 Hz, C ); 130.3 (C ); 64.7 (CH); 54.9
12.27. Found: C, 58.20; H, 7.52; N, 12.16.
C3-F
3
5
19
(OCH ); 23.4 (CH ); F NMR (deuteriochloroform, 300 MHz): δ
3
3
3-Chloro-6-fluoro-5-(1-hydroxyethyl)pyridazine (13) and 3,6-
Dichloro-4-(1-hydroxyethyl)pyridazine (14).
-1
= -83.82. IR (KBr) (cm ): 3401; 2981; 2949; 1595; 1538; 1490;
1447; 1424; 1389; 1331; 1179; 1155; 1091; 1039; 1017; 978; 899.
Metalation of the mixture (160 mg, 1.18 mmol) of 3-chloro-6-
fluoropyridazine (67 %, 0.81 mmol), 3,6-dichloropyridazine (28
%, 0.30 mmol) and 3,6-difluoropyridazine (5 %, 0.07 mmol) was
performed according to the general procedure with n-butyllithium
1.6 M (1.2 equiv., 0.89 mL), 2,2,6,6-tetramethylpiperidine (1.3
Anal. Calcd. for C H FN O (172.16): C, 48.84; H, 5.27; N,
16.27. Found: C, 48.67; H, 5.56; N, 16.06.
7
9
2 2
2-Fluoro-5-(1-hydroxyethyl)-6-methoxypyrazine (8b).
Metalation of 2 (156 mg, 1.22 mmol) was performed accord-
ing to the general procedure with n-butyllithium 1.6 M (2.2
equiv., 1.67 mL), 2,2,6,6-tetramethylpiperidine (2.3 equiv., 0.47
mL), t = 5 min, θ = -78 °C, followed by reaction with acetalde-
equiv., 0.26 mL), t = 90 min, θ = -78 °C, followed by reaction
1
1
with acetaldehyde in excess, t = 60 min, θ = -78 °C gave after
2
2
purification by column chromatography (silica, eluent: petroleum
ether/ethylacetate (2/1)) 138 mg (63 %) of an untractable mixture
1
1
hyde in excess, t = 60 min, θ = -78 °C gave after purification by
2
2
1
column chromatography (silica, eluent: petroleum
ether/dichloromethane (1/1)) 167 mg (78 %) of a pale yellow oil
containing 77 % of 13 + 15 and 23 % of 14; H NMR (deuteri-
ochloroform, 300 MHz): 13, δ = 7.85 (d, 1H, J
= 7.9 Hz, H );
H4-F
4
1
containing 88 % of 8a and 12 % of 8b; H NMR (deuteriochloro-
5.07 (q, 1H, J
= 6.4 Hz, CH); 1.48 (d, 3H, J
= 6.4
CH3-CH
CH-CH3
1
form, 300 MHz): 8b, δ = 7.81 (d, 1H, J
= 8.3 Hz, H ); 4.99
Hz, CH ); H NMR (deuteriochloroform, 300 MHz): 14, δ = 7.83
H3-F
3
3
(m, 1H, CH); 3.93 (s, 3H, OCH ); 3.63 (br, 1H, OH); 1.37 (d, 3H,
(s, 1H, H ); 5.07 (q, 1H, J
= 6.4 Hz, CH); 1.48 (d, 3H,
3
5
CH-CH3
13
19
J = 6.4 Hz, CH ); F NMR (deuteriochloroform, 300 MHz): 8b,
J
= 6.4 Hz, CH ); C NMR (deuteriochloroform, 300
3
CH3-CH
3
-1
δ = -88.09. IR (KBr) for the mixture of 8a and 8b (cm ): 3400;
MHz) 13: 163.8 (d, J
= 245.6 Hz, C ); 155.9 (C ); 139.3 (d,
6 3
C6-F
13
2981; 2949; 1682; 1594; 1538; 1489; 1446; 1424; 1391; 1331;
1179; 1155; 1091; 1039; 978.
J
= 27.6 Hz, C ); 130.3 (C ); 63.4 (CH); 23.7 (CH );
C
C5-F
5
4
3
NMR (deuteriochloroform, 300 MHz): 14, 157.2 (C or C );
3
6
Anal. Calcd. for the mixture of 8a and 8b C H FN O
(172.16): C, 48.84; H, 5.27; N, 16.27. Found: C, 48.89; H, 5.33;
N, 16.55.
154.2 (C or C ); 149.2 (C ); 127.8 (C ); 65.9 (CH); 23.3 (CH );
F NMR (deuteriochloroform, 200 MHz): 13, -87.05.
7
9
2
2
3
6
4
5
3
19
3-Chloro-6-fluoro-5-(1-hydroxyphenylmethyl)pyridazine (16)
and 3,6-Dichloro-4-(1-hydroxyphenylmethyl)pyridazine (17).
2-Fluoro-3-(1-hydroxyhexyl)-6-methoxypyrazine (9a).
Metalation of 7 (159 mg, 1.24 mmol) was performed accord-
ing to the general procedure with n-butyllithium 1.6 M (2.2
Metalation of the mixture (152 mg, 1.12 mmol) of 3-chloro-6-
fluoropyridazine (67 %, 0.77 mmol), 3,6-dichloropyridazine (28
%, 0.29 mmol) and 3,6-difluoropyridazine (5 %, 0.06 mmol) was
performed according to the general procedure with n-butyllithium
1.6 M (1.2 equiv., 0.84 mL), 2,2,6,6-tetramethylpiperidine (1.3
equiv., 1.71 mL), diisopropylamine (2.3 equiv., 0.40 mL), t = 5
1
min, θ = -78 °C, followed by reaction with hexanal (2.2 equiv.,
1
0.33 mL), t = 60 min, θ = -78 °C gave after purification by col-
2
2
umn chromatography (silica, eluent: petroleum ether/ethylacetate
(14/1)) 210 mg (74 %) of 9a as a colorless liquid; H NMR (deu-
equiv., 0.25 mL), t = 90 min, θ = -78 °C, followed by reaction
1
1
1
with benzaldehyde (1.5 equiv., 0.17 mL), t = 60 min, θ = -78 °C
2
2
teriochloroform, 300 MHz): δ = 7.99 (d, 1H, J
4.81 (t, 1H, J = 6.4 Hz, CH); 3.87 (s, 3H, OCH ); 3.57 (br, 1H,
= 3.4 Hz, H )
gave after purification by column chromatography (silica, eluent:
petroleum ether/ethylacetate (2/1)) 150 mg (55 %) of an unsepara-
ble mixture containing 72 % of 16 + 18 and 28 % of 17; H NMR
H5-F
5
3
1
OH); 1.66 (m, 2H, CH ); 1.33-1.17 (m, 6H, 3CH ); 0.77 (m, 3H,
2
2
13
CH ); C NMR (deuteriochloroform, 300 MHz): δ = 158.7 (C );
(deuteriochloroform, 300 MHz): 16, 7.90 (d, 1H, J
= 7.7 Hz,
3
6
H4-F
1
155.1 (d, J
= 255.8 Hz, C ); 135.5 (d, J
= 28.3 Hz, C );
H ); 7.20 (m, 5H, 5H ); 5.85 (s, 1H, CH); 3.92 (br , 1H, OH); H
C2-F
2
C3-F
3
4
Ph
130.4 (C ); 68.2 (CH); 54.7 (OCH ); 37.4 (CH ); 31.9 (CH );
NMR (deuteriochloroform, 300 MHz): 17, 7.92 (s, 1H, H ); 7.20
5
3
2
2
5
19
25.2 (CH ); 22.8 (CH ); 14.2 (CH ); F NMR (deuteriochloro-
(m, 5H, 5H ); 5.85 (s, 1H, CH); 3.92 (br, 1H, OH).
2
2
3
Ph
-1
form, 300 MHz): δ = -84.33. IR (KBr) (cm ): 3411; 2932; 2860;
1595; 1540; 1488; 1459; 1425; 1389; 1331; 1177; 1150; 1113;
1039; 979.
3-Chloro-6-Fluoro-5-iodopyridazine (19) and 3,6-Dichloro-4-
iodopyridazine (20).
Metalation of the mixture (174 mg, 1.28 mmol) of 3-chloro-6-
fluoropyridazine (67 %, 0.88 mmol), 3,6-dichloropyridazine (28
%, 0.33 mmol) and 3,6-difluoropyridazine (5 %, 0.07 mmol) was
performed according to the general procedure with n-butyl-
lithium 1.6 M (1.2 equiv., 0.96 mL), 2,2,6,6-tetramethylpiperi-
Anal. Calcd. for C H FN O (228.27): C, 57.88; H, 7.51; N,
12.27. Found: C, 57.87; H, 7.61; N, 12.36.
11 17
2 2
2-Fluoro-5-(1-hydroxyhexyl)-6-methoxypyrazine (9b).
Metalation of 7 (156 mg, 1.22 mmol) was performed accord-
ing to the general procedure with n-butyllithium 1.6 M (2.2
equiv., 1.67 mL), 2,2,6,6-tetramethylpiperidine (2.3 equiv., 0.47
mL), t = 5 min, θ = -78 °C, followed by reaction with hexanal
dine (1.3 equiv., 0.28 mL), t = 90 min, θ = -78 °C, followed by
1
1
reaction with iodine (1.1 equiv., 357 mg), t = 60 min, θ = -78
2
2
°C gave after purification by column chromatography (silica,
eluent: petroleum ether/dichloromethane (2/1)) 123 mg (37 %) of
an unseparable mixture containing 77 % of 19 + 21 and 23 % of
1
1
(2.2 equiv., 0.32 mL), t = 60 min, θ = -78 °C gave after purifi-
2
2
cation by column chromatography (silica, eluent: petroleum
1
ether/ethylacetate (14/1)) 15 mg (5 %) of 9b as a colorless liquid
20; H NMR (deuteriochloroform, 300 MHz): 19, 8.03 (d, 1H,
1
1
(besides 169 mg (60 %) of 9a); H NMR (deuteriochloroform,
J
= 6.6 Hz, H ); H NMR (deuteriochloroform, 300 MHz):
H4-F
4
300 MHz): δ = 7.82 (d, 1H, J
= 8.3 Hz, H ); 4.82 (m, 1H,
20, 7.99 (s, 1H, H ).
H3-F
3
5